A waitlist-controlled trial of group cognitive behavioural therapy for depression and anxiety in Parkinson’s disease
Background: The aim of this study was to evaluate the efficacy of a group Cognitive Behavioural Therapy (CBT) treatment for depression and anxiety in Parkinson’s disease (PD). Methods: A waitlist-controlled trial design was used. Eighteen adults with PD and a comorbid DSM-IV-TR diagnosis of depressi...
| Main Authors: | , , |
|---|---|
| Format: | Journal Article |
| Published: |
BioMed Central Ltd.
2014
|
| Subjects: | |
| Online Access: | http://hdl.handle.net/20.500.11937/12104 |
| _version_ | 1848747985332076544 |
|---|---|
| author | Troeung, Lakkhina Egan, Sarah Gasson, Natalie |
| author_facet | Troeung, Lakkhina Egan, Sarah Gasson, Natalie |
| author_sort | Troeung, Lakkhina |
| building | Curtin Institutional Repository |
| collection | Online Access |
| description | Background: The aim of this study was to evaluate the efficacy of a group Cognitive Behavioural Therapy (CBT) treatment for depression and anxiety in Parkinson’s disease (PD). Methods: A waitlist-controlled trial design was used. Eighteen adults with PD and a comorbid DSM-IV-TR diagnosis of depression and/or anxiety were randomised to either Intervention (8-week group CBT treatment) or Waitlist (8-week clinical monitoring preceding treatment). The Depression, Anxiety, Stress Scale-21 (DASS-21) was the primary outcome. Assessments were completed at Time 1 (pretreatment), Time 2 (posttreatment/post-waitlist) and 1-month and 6-month follow-ups. Results: At Time 2, participants who received CBT reported greater reductions in depression (Mchange = -2.45) than Waitlist participants (Mchange = .29) and this effect was large, d = 1.12, p = .011. Large secondary effects on anxiety were also observed for CBT participants, d = .89, p = .025. All treatment gains were maintained and continued to improve during the follow-up period. At 6-month follow-up, significant and large effects were observed for both depression (d = 2.07) and anxiety (d = 2.26). Conclusions: Group CBT appears to be an efficacious treatment approach for depression and anxiety in PD however further controlled trials with larger numbers of participants are required. |
| first_indexed | 2025-11-14T06:57:51Z |
| format | Journal Article |
| id | curtin-20.500.11937-12104 |
| institution | Curtin University Malaysia |
| institution_category | Local University |
| last_indexed | 2025-11-14T06:57:51Z |
| publishDate | 2014 |
| publisher | BioMed Central Ltd. |
| recordtype | eprints |
| repository_type | Digital Repository |
| spelling | curtin-20.500.11937-121042017-09-13T14:59:18Z A waitlist-controlled trial of group cognitive behavioural therapy for depression and anxiety in Parkinson’s disease Troeung, Lakkhina Egan, Sarah Gasson, Natalie Parkinson’s disease Depression Anxiety Psychotherapy Randomised controlled trial Cognitive behavioural therapy Treatment Background: The aim of this study was to evaluate the efficacy of a group Cognitive Behavioural Therapy (CBT) treatment for depression and anxiety in Parkinson’s disease (PD). Methods: A waitlist-controlled trial design was used. Eighteen adults with PD and a comorbid DSM-IV-TR diagnosis of depression and/or anxiety were randomised to either Intervention (8-week group CBT treatment) or Waitlist (8-week clinical monitoring preceding treatment). The Depression, Anxiety, Stress Scale-21 (DASS-21) was the primary outcome. Assessments were completed at Time 1 (pretreatment), Time 2 (posttreatment/post-waitlist) and 1-month and 6-month follow-ups. Results: At Time 2, participants who received CBT reported greater reductions in depression (Mchange = -2.45) than Waitlist participants (Mchange = .29) and this effect was large, d = 1.12, p = .011. Large secondary effects on anxiety were also observed for CBT participants, d = .89, p = .025. All treatment gains were maintained and continued to improve during the follow-up period. At 6-month follow-up, significant and large effects were observed for both depression (d = 2.07) and anxiety (d = 2.26). Conclusions: Group CBT appears to be an efficacious treatment approach for depression and anxiety in PD however further controlled trials with larger numbers of participants are required. 2014 Journal Article http://hdl.handle.net/20.500.11937/12104 10.1186/1471-244X-14-19 BioMed Central Ltd. fulltext |
| spellingShingle | Parkinson’s disease Depression Anxiety Psychotherapy Randomised controlled trial Cognitive behavioural therapy Treatment Troeung, Lakkhina Egan, Sarah Gasson, Natalie A waitlist-controlled trial of group cognitive behavioural therapy for depression and anxiety in Parkinson’s disease |
| title | A waitlist-controlled trial of group cognitive behavioural therapy for depression and anxiety in Parkinson’s disease |
| title_full | A waitlist-controlled trial of group cognitive behavioural therapy for depression and anxiety in Parkinson’s disease |
| title_fullStr | A waitlist-controlled trial of group cognitive behavioural therapy for depression and anxiety in Parkinson’s disease |
| title_full_unstemmed | A waitlist-controlled trial of group cognitive behavioural therapy for depression and anxiety in Parkinson’s disease |
| title_short | A waitlist-controlled trial of group cognitive behavioural therapy for depression and anxiety in Parkinson’s disease |
| title_sort | waitlist-controlled trial of group cognitive behavioural therapy for depression and anxiety in parkinson’s disease |
| topic | Parkinson’s disease Depression Anxiety Psychotherapy Randomised controlled trial Cognitive behavioural therapy Treatment |
| url | http://hdl.handle.net/20.500.11937/12104 |